Aralez Pharmaceuticals Inc. (TSX:ARZ) is seeking acquisitions. Aralez has access to $200 million of committed debt capital eligible for acquisitions pursuant to a financing that was completed in connection with the acquisition of Tribute Pharmaceuticals Canada Inc.